Argentina is one of the 35 countries worldwide where the vaccine to combat the coronavirus is manufactured, together with Brazil and Mexico. In the AstraZeneca vaccine, the active ingredient part produced in the MAbxience laboratory, where 90 million doses have been made and expect to reach 180 million this year. Sputnik V's fractionation and packaging part carry out since last week at the MR Pharma laboratory, where they hope to produce 5 million doses per month. On the other hand, negotiations are progressing to make the Chinese vaccine Sinopharm at Sinergium Biotech part of the Insud Group.
In only five months and with the pandemic far from its end, government spending on the coronavirus increased 309%. By May, the government spent 125.43 billion pesos ($1.31 billion) on covid, which leaves almost 70% remaining of the budget and credits to face the pandemic. Source: Ámbito
The fertilizer company Profertil completed the placement of its first debentures for a total amount of $25 million. The issue was made through the dollar link instrument, at a rate of 2.49%, with a maturity of 24 months. Molinos Agro followed the same path, which weeks ago placed debentures for a total of $53.8 million. Morixe made its first issue of debentures for $4.2 million on the local stock exchange in June. The seed company Asociados Don Mario will launch its Series VI for up to $8 million.
Cresud, one of the largest agricultural companies in the country, launched an exchange of debentures for $35.7 million that are part of an issue maturing next July 11 for a total of $59.5 million. The transaction opened last Friday, and the deadline to enter will be Monday, 28th of this month.
The BASF group of chemical companies recorded a 50% increase in users of its online sales platform for inputs for small and medium-sized companies in Argentina and other Southern Cone countries. The online sales platform is the first of its kind in the chemical sector and had a 50% growth in registered customers between 2019 and 2020.